Is G1 Therapeutics, Inc. (GTHX) a Buy, Sell, or Hold?
G1 Therapeutics, Inc.
NASDAQ:GTHX
$7.16 USD
$0.01 (0.14%)
- Volume
- 1.1M
- Average Volume
- 2.18M
- Market Capitalization
- $377.75M
- P/E Ratio
- -7.70
- Dividend Yield
- 0.00%
- Price Target
- $4.50
- Year High
- $7.19
- Year Low
- $1.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.87
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
43
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
97
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 4.3M
GTHX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
GTHX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Secor Alicia | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Secor Alicia | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| Secor Alicia | director | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Secor Alicia | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| Secor Alicia | director | 2024-09-18 | D-Return | 5.3 | 2024-09-18 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-09-18 | D-Return | 2.88 | 2024-09-18 |
| Flowers Cynthia Louise | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Flowers Cynthia Louise | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| Flowers Cynthia Louise | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| Flowers Cynthia Louise | director | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Flowers Cynthia Louise | director | 2024-09-18 | D-Return | 5.3 | 2024-09-18 |
| Nicholson Garry A | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Lee Jacks | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Nicholson Garry A | director | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Nicholson Garry A | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| Lee Jacks | director | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Lee Jacks | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| Lee Jacks | director | 2024-09-18 | D-Return | 5.35 | 2024-09-18 |
| Nicholson Garry A | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| Lee Jacks | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| Nicholson Garry A | director | 2024-09-18 | D-Return | 5.3 | 2024-09-18 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-09-18 | A-Award | 0 | 2024-09-18 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-09-18 | D-Return | 3.27 | 2024-09-18 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | A-Award | 0 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | D-Return | 4.17 | 2024-09-18 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-09-18 | D-Return | 3.72 | 2024-09-18 |
| Avagliano Mark | officer: Chief Business Officer | 2024-09-18 | A-Award | 0 | 2024-09-18 |
| Avagliano Mark | officer: Chief Business Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Avagliano Mark | officer: Chief Business Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Avagliano Mark | officer: Chief Business Officer | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| Sharpless Norman | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| Avagliano Mark | officer: Chief Business Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Sharpless Norman | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| Sharpless Norman | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-09-18 | A-Award | 0 | 2024-09-18 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-09-18 | A-Award | 0 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-09-18 | D-Return | 2.97 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-09-18 | D-Return | 5.73 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | D-Return | 7.15 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | D-Return | 5.3 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | U-Tender | 0 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | D-Return | 2.99 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | D-Return | 2.83 | 2024-09-18 |
| MUIR GLENN P | director | 2024-09-18 | D-Return | 0.3 | 2024-09-18 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| Avagliano Mark | officer: Chief Business Officer | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-07-05 | S-Sale | 2.5077 | 2024-07-08 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| Avagliano Mark | officer: Chief Business Officer | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-07-01 | A-Award | 0 | 2024-07-03 |
| Sharpless Norman | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| Sharpless Norman | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| Secor Alicia | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| Secor Alicia | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| MUIR GLENN P | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| MUIR GLENN P | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| Lee Jacks | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| Lee Jacks | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| Flowers Cynthia Louise | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| Flowers Cynthia Louise | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| Nicholson Garry A | director | 2024-06-13 | A-Award | 0 | 2024-06-14 |
| Nicholson Garry A | director | 2024-06-13 | A-Award | 2.99 | 2024-06-14 |
| Thomas Monica R. | officer: Chief Legal & People Officer | 2024-05-23 | S-Sale | 4.2678 | 2024-05-24 |
| Perry Andrew | officer: Chief Commercial Officer | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| MURDOCK TERRY L | officer: Chief Operating Officer | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| Malik Rajesh | officer: Chief Medical Officer | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| Avagliano Mark | officer: Chief Business Officer | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| Bailey John E. (Jack) Jr. | director, officer: President and CEO | 2024-05-13 | S-Sale | 4.7888 | 2024-05-15 |
| Thomas Monica R. | officer: General Counsel | 2024-03-20 | A-Award | 0 | 2024-03-22 |
| Avagliano Mark | officer: Chief Business Officer | 2024-03-20 | A-Award | 0 | 2024-03-22 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-03-20 | A-Award | 0 | 2024-03-22 |
| Umstead John W. V | officer: Chief Financial Officer | 2024-03-18 | S-Sale | 3.0169 | 2024-03-20 |